Articles
| Open Access |
DOI: Prevention Of Anemia In Patients With Tuberculosis
Mamatkulova Feruza Xaydarovna , Samarkand State Medical Institute, Teacher Of The Department Of Hematology, Uzbekistan Mamatova Nargiza Toirjonovna , Samarkand Medical Institute, Lecturer At The Department Of Phthisiology, Uzbekistan Ruziboeva Oyjamol Narzullaevna , Samarkand Medical Institute, Teacher Of The Department Of Hematology, UzbekistanAbstract
This article include prevention of anemia in patients with tuberculosis. tuberculosis induces a systemic inflammatory state affecting iron homeostasis. patients with tuberculosis often have additional comorbidities such as anemia which can result in poorer treat outcomes. we studied the contribution of anemia and the role of the iron regulatory hormone hepcidin among tuberculosis patients and household contacts.
Keywords
Tuberculosis, anemia
References
Faris P.M. The effects of recombinant human erythropoietin on perioperative transfusion requirements in patients having a major orthopedic operation / P.M. Faris,M.A. Ritter, R.I. Abels; The American Erythropoietin Study Group // J Bone Joint Surg Am. - 1996
Kumar A. Perioperative management of anemia: Limits of blood transfusion and alternatives to it / A. Kumar // Cleveland Clinic Journal of Medicine. - 2009.
Laupacis A. Erythropoietin to minimize perioperative blood transfusion: a systematic review of randomized trials. The International Study of Preoperative Transfusion (ISPOT) Investigators / - 1998.
The Prevalence and Evolution of Anemia Associated wich Tuberculosis / W. Lee J. Korean. Med. Sci. - 2006.
Preoperative administration of epoetin alfa to reduce transfusion requirements in elderly patients having primary total hip or knee reconstruction / R.A. Lofthouse [etal.] // J South Orthop Assoc. - 2000.
Article Statistics
Copyright License
Copyright (c) 2020 The American Journal of Medical Sciences and Pharmaceutical Research
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors retain the copyright of their manuscripts, and all Open Access articles are disseminated under the terms of the Creative Commons Attribution License 4.0 (CC-BY), which licenses unrestricted use, distribution, and reproduction in any medium, provided that the original work is appropriately cited. The use of general descriptive names, trade names, trademarks, and so forth in this publication, even if not specifically identified, does not imply that these names are not protected by the relevant laws and regulations.